Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Hong Kong
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Supply Chain

China Renji Medical Group Ltd/Hong Kong

+ Add to Watchlist

648:HK

0.420 HKD 0.020 5.00%

As of 04:01:05 ET on 06/02/2015.

Snapshot for China Renji Medical Group Ltd/Hong Kong (648)

Open: 0.430 Day's Range: 0.405 - 0.445 Volume: 80,254,450
Previous Close: 0.400 52wk Range: 0.185 - 0.574 1-Yr Rtn: -15.42%

Stock Chart for 648

No chart data available.
  • 648:HK 0.420
  • 1D
  • 1M
  • 1Y
0.400
Interactive 648 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 648

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. HSI -
Earnings Per Share (ttm) -0.0544
Est. EPS -
Est. PEG Ratio -
Market Cap (M HKD) 761.99
Shares Outstanding (M) 1,814.27
30 Day Average Volume 44,097,960
Price/Book (mrq) 0.8078
Price/Sale (ttm) 4.3458
Dividend Indicated Gross Yield -%
Cash Dividend (HKD) -
Dividend Ex-Date 12/12/1995
5 Year Dividend Growth -
Next Earnings Announcement 08/28/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 648

  • Revenue
  • Net Income (M/HKD)
  • Profit Margin (%)

Company Profile & Key Executives for 648

China Renji Medical Group Limited, through its subsidiaries, manages and operates a network of medical centers specializing in the diagnosis and treatment of tumors and cancer in China.

Chan Ka ChungChairmanWang JianguoExecutive Director
Cheung Wai KwanExecutive DirectorLam Sung Him "Gaston"Secretary
More Company Profile & Key Executives for 648

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil